03/25/2016
Federal Register Notice: FDA is making available a draft guidance: General Principles for Evaluating the Abuse Deterrence of Gener...03/10/2016
Federal Register Notice: CDRH will sponsor the 2016 Experiential Learning Program (ELP). The training component is intended to pro...03/10/2016
Federal Register Notice: FDA seeks public comments on the information collection associated with the guidance for industry and FDA...03/10/2016
Federal Register Notice: FDA proposed collection of information “Investigational Device Exemptions Reports and Records,&rdqu...03/10/2016
Federal Register Notice: FDA’s proposed collection of information, “Emergency Use Authorization of Medical Products an...03/10/2016
Federal Register Notice: FDA has determined the regulatory review period for Actelion Pharmaceuticals’ Opsumit (macitentan) ...03/10/2016
Federal Register Proposed rule: FDA is proposing to classify posterior cervical screw systems into Class 2 (special controls) and ...02/18/2016
Federal Register Notice: FDA is requesting that any industry organizations interested in participating in the selecting nonvoting ...